Jacob Hanna, MD
Psychiatry · Macon, GANPI 1093202475
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 96.3% of the total across 135 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 18 manufacturers, the largest accounting for just 16.4% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,446, more than ten times the $40 reported in 2021.
Across 135 payments — averaging $22.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$491
- Johnson & Johnson$398
- Teva Pharmaceuticals USA, Inc.$341
- AbbVie$243
- Otsuka America Pharmaceutical, Inc.$234
- Lundbeck LLC$220
- plus $1K from 12 others
What the payments were for
- Food & beverage$2,87996%
- Education$1114%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 24 | $491 |
| Johnson & Johnson(2 entities) | 19 | $398 |
| Teva Pharmaceuticals USA, Inc. | 14 | $341 |
| AbbVie | 12 | $243 |
| Otsuka America Pharmaceutical, Inc. | 11 | $234 |
| Lundbeck LLC | 11 | $220 |
| Neurocrine Biosciences, Inc. | 5 | $152 |
| E.r. Squibb & Sons, L.L.C. | 8 | $149 |
| Brainsway USA Inc | 1 | $143 |
| Corium, LLC | 5 | $122 |
| Alkermes, Inc. | 6 | $108 |
| Vanda Pharmaceuticals Inc. | 4 | $90 |
| Axsome Therapeutics, Inc. | 3 | $81 |
| Idorsia Pharmaceuticals US Inc | 4 | $72 |
| Collegium Pharmaceutical, Inc. | 2 | $47 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $46 |
| Supernus Pharmaceuticals, Inc. | 2 | $31 |
| Biogen | 1 | $23 |
How this compares
$2,991 in reported general payments places this provider in the 80th percentile of 900 psychiatry providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Aripiprazole | 16 | $1,357 |
| Quetiapine Fumarate | 79 | $1,094 |
| Bupropion XlBupropion Hcl | 42 | $1,081 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 11 | $685 |
| Mirtazapine | 44 | $491 |
| Paroxetine ErParoxetine Hcl | 11 | $461 |
| Doxepin Hcl | 16 | $438 |
| Duloxetine Hcl | 20 | $410 |
| Gabapentin | 42 | $410 |
| Sertraline Hcl | 61 | $408 |
| Pregabalin | 12 | $364 |
| Buspirone Hcl | 27 | $303 |
| Clonazepam | 27 | $275 |
| Trazodone Hcl | 48 | $166 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 11 | $165 |
Paid to pharmacies, not to this prescriber.
Other psychiatry in Macon
- Angela EubanksMacon$30K
- Richard PettyLoganville$2.9M
- Ann GrooverCalhoun$1.4M
- Todd AntinDecatur$1M
- Michael BanovMarietta$733K
- Ben HunterBrookhaven$499K
- Joel MorganValdosta$337K
- Munjal ShroffSmyrna$316K
- David PurselleAtlanta$307K
- Jose CangianoAthens$244K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.